Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Tumor Ablation Needle Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Tumor Ablation Needle Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 176 Pages
Report ld: 5344730
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Tumor Ablation Needle Market Size(US$)
CAGR 2025-2031
8.5%
Market Size,2031
USD 2,119
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,299 million
Market Forecast in 2031(Value)
US$ 2,119 million
CAGR
8.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Tumor Ablation Needle market is projected to grow from US$ 1207 million in 2024 to US$ 2119 million by 2031, at a CAGR of 8.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Tumor Ablation Needle market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Angiodynamics
- Boston Scientific
- Medtronic
- Smith and Nephew
- Starmed
- Siemens
- PAJUNK
- Johnson and Johnson
- Med-Italia Biomedica
- Thermedical
- Erbe Elektromedizin GmbH
- Betters Medical
- Nanjing ECO Microwave System
- Nanjing MICRO-TECH
- VISON Medical
- Nanjing Greatwall Wisemedical Tech
- Angel Medical Science and Technology
- Leader Electronics
- Zhuhai Hokai Medical
- MedSphere International
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Microwave Ablation Needle
- Radiofrequency Ablation Needle
- Cryoablation Needle
- Nanoknife Ablation Needle
Segment by Application
- Hospital
- Ambulatory Surgery Center
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Tumor Ablation Needle study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Tumor Ablation Needle: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Tumor Ablation Needle Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Microwave Ablation Needle
1.2.3 Radiofrequency Ablation Needle
1.2.4 Cryoablation Needle
1.2.5 Nanoknife Ablation Needle
1.3 Market Segmentation by Application
1.3.1 Global Tumor Ablation Needle Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tumor Ablation Needle Revenue Estimates and Forecasts 2020-2031
2.2 Global Tumor Ablation Needle Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Tumor Ablation Needle Sales Estimates and Forecasts 2020-2031
2.4 Global Tumor Ablation Needle Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Tumor Ablation Needle Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Tumor Ablation Needle Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Microwave Ablation Needle Market Size by Manufacturers
3.5.2 Radiofrequency Ablation Needle Market Size by Manufacturers
3.5.3 Cryoablation Needle Market Size by Manufacturers
3.5.4 Nanoknife Ablation Needle Market Size by Manufacturers
3.6 Global Tumor Ablation Needle Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Tumor Ablation Needle Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Tumor Ablation Needle Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Tumor Ablation Needle Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Tumor Ablation Needle Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Tumor Ablation Needle Sales and Revenue by Type (2020-2031)
6.4 North America Tumor Ablation Needle Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Tumor Ablation Needle Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Tumor Ablation Needle Sales and Revenue by Type (2020-2031)
7.4 Europe Tumor Ablation Needle Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Tumor Ablation Needle Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Tumor Ablation Needle Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Tumor Ablation Needle Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Tumor Ablation Needle Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Tumor Ablation Needle Sales and Revenue by Type (2020-2031)
9.4 Central and South America Tumor Ablation Needle Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Tumor Ablation Needle Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Tumor Ablation Needle Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Tumor Ablation Needle Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Tumor Ablation Needle Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Angiodynamics
11.1.1 Angiodynamics Corporation Information
11.1.2 Angiodynamics Business Overview
11.1.3 Angiodynamics Tumor Ablation Needle Product Models, Descriptions and Specifications
11.1.4 Angiodynamics Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Angiodynamics Tumor Ablation Needle Sales by Product in 2024
11.1.6 Angiodynamics Tumor Ablation Needle Sales by Application in 2024
11.1.7 Angiodynamics Tumor Ablation Needle Sales by Geographic Area in 2024
11.1.8 Angiodynamics Tumor Ablation Needle SWOT Analysis
11.1.9 Angiodynamics Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Corporation Information
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Tumor Ablation Needle Product Models, Descriptions and Specifications
11.2.4 Boston Scientific Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Boston Scientific Tumor Ablation Needle Sales by Product in 2024
11.2.6 Boston Scientific Tumor Ablation Needle Sales by Application in 2024
11.2.7 Boston Scientific Tumor Ablation Needle Sales by Geographic Area in 2024
11.2.8 Boston Scientific Tumor Ablation Needle SWOT Analysis
11.2.9 Boston Scientific Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Tumor Ablation Needle Product Models, Descriptions and Specifications
11.3.4 Medtronic Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic Tumor Ablation Needle Sales by Product in 2024
11.3.6 Medtronic Tumor Ablation Needle Sales by Application in 2024
11.3.7 Medtronic Tumor Ablation Needle Sales by Geographic Area in 2024
11.3.8 Medtronic Tumor Ablation Needle SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Smith and Nephew
11.4.1 Smith and Nephew Corporation Information
11.4.2 Smith and Nephew Business Overview
11.4.3 Smith and Nephew Tumor Ablation Needle Product Models, Descriptions and Specifications
11.4.4 Smith and Nephew Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Smith and Nephew Tumor Ablation Needle Sales by Product in 2024
11.4.6 Smith and Nephew Tumor Ablation Needle Sales by Application in 2024
11.4.7 Smith and Nephew Tumor Ablation Needle Sales by Geographic Area in 2024
11.4.8 Smith and Nephew Tumor Ablation Needle SWOT Analysis
11.4.9 Smith and Nephew Recent Developments
11.5 Starmed
11.5.1 Starmed Corporation Information
11.5.2 Starmed Business Overview
11.5.3 Starmed Tumor Ablation Needle Product Models, Descriptions and Specifications
11.5.4 Starmed Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Starmed Tumor Ablation Needle Sales by Product in 2024
11.5.6 Starmed Tumor Ablation Needle Sales by Application in 2024
11.5.7 Starmed Tumor Ablation Needle Sales by Geographic Area in 2024
11.5.8 Starmed Tumor Ablation Needle SWOT Analysis
11.5.9 Starmed Recent Developments
11.6 Siemens
11.6.1 Siemens Corporation Information
11.6.2 Siemens Business Overview
11.6.3 Siemens Tumor Ablation Needle Product Models, Descriptions and Specifications
11.6.4 Siemens Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Siemens Recent Developments
11.7 PAJUNK
11.7.1 PAJUNK Corporation Information
11.7.2 PAJUNK Business Overview
11.7.3 PAJUNK Tumor Ablation Needle Product Models, Descriptions and Specifications
11.7.4 PAJUNK Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 PAJUNK Recent Developments
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Corporation Information
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Tumor Ablation Needle Product Models, Descriptions and Specifications
11.8.4 Johnson and Johnson Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Johnson and Johnson Recent Developments
11.9 Med-Italia Biomedica
11.9.1 Med-Italia Biomedica Corporation Information
11.9.2 Med-Italia Biomedica Business Overview
11.9.3 Med-Italia Biomedica Tumor Ablation Needle Product Models, Descriptions and Specifications
11.9.4 Med-Italia Biomedica Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Med-Italia Biomedica Recent Developments
11.10 Thermedical
11.10.1 Thermedical Corporation Information
11.10.2 Thermedical Business Overview
11.10.3 Thermedical Tumor Ablation Needle Product Models, Descriptions and Specifications
11.10.4 Thermedical Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Thermedical Recent Developments
11.11 Erbe Elektromedizin GmbH
11.11.1 Erbe Elektromedizin GmbH Corporation Information
11.11.2 Erbe Elektromedizin GmbH Business Overview
11.11.3 Erbe Elektromedizin GmbH Tumor Ablation Needle Product Models, Descriptions and Specifications
11.11.4 Erbe Elektromedizin GmbH Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Erbe Elektromedizin GmbH Recent Developments
11.12 Betters Medical
11.12.1 Betters Medical Corporation Information
11.12.2 Betters Medical Business Overview
11.12.3 Betters Medical Tumor Ablation Needle Product Models, Descriptions and Specifications
11.12.4 Betters Medical Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Betters Medical Recent Developments
11.13 Nanjing ECO Microwave System
11.13.1 Nanjing ECO Microwave System Corporation Information
11.13.2 Nanjing ECO Microwave System Business Overview
11.13.3 Nanjing ECO Microwave System Tumor Ablation Needle Product Models, Descriptions and Specifications
11.13.4 Nanjing ECO Microwave System Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Nanjing ECO Microwave System Recent Developments
11.14 Nanjing MICRO-TECH
11.14.1 Nanjing MICRO-TECH Corporation Information
11.14.2 Nanjing MICRO-TECH Business Overview
11.14.3 Nanjing MICRO-TECH Tumor Ablation Needle Product Models, Descriptions and Specifications
11.14.4 Nanjing MICRO-TECH Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Nanjing MICRO-TECH Recent Developments
11.15 VISON Medical
11.15.1 VISON Medical Corporation Information
11.15.2 VISON Medical Business Overview
11.15.3 VISON Medical Tumor Ablation Needle Product Models, Descriptions and Specifications
11.15.4 VISON Medical Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 VISON Medical Recent Developments
11.16 Nanjing Greatwall Wisemedical Tech
11.16.1 Nanjing Greatwall Wisemedical Tech Corporation Information
11.16.2 Nanjing Greatwall Wisemedical Tech Business Overview
11.16.3 Nanjing Greatwall Wisemedical Tech Tumor Ablation Needle Product Models, Descriptions and Specifications
11.16.4 Nanjing Greatwall Wisemedical Tech Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Nanjing Greatwall Wisemedical Tech Recent Developments
11.17 Angel Medical Science and Technology
11.17.1 Angel Medical Science and Technology Corporation Information
11.17.2 Angel Medical Science and Technology Business Overview
11.17.3 Angel Medical Science and Technology Tumor Ablation Needle Product Models, Descriptions and Specifications
11.17.4 Angel Medical Science and Technology Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Angel Medical Science and Technology Recent Developments
11.18 Leader Electronics
11.18.1 Leader Electronics Corporation Information
11.18.2 Leader Electronics Business Overview
11.18.3 Leader Electronics Tumor Ablation Needle Product Models, Descriptions and Specifications
11.18.4 Leader Electronics Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Leader Electronics Recent Developments
11.19 Zhuhai Hokai Medical
11.19.1 Zhuhai Hokai Medical Corporation Information
11.19.2 Zhuhai Hokai Medical Business Overview
11.19.3 Zhuhai Hokai Medical Tumor Ablation Needle Product Models, Descriptions and Specifications
11.19.4 Zhuhai Hokai Medical Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Zhuhai Hokai Medical Recent Developments
11.20 MedSphere International
11.20.1 MedSphere International Corporation Information
11.20.2 MedSphere International Business Overview
11.20.3 MedSphere International Tumor Ablation Needle Product Models, Descriptions and Specifications
11.20.4 MedSphere International Tumor Ablation Needle Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 MedSphere International Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Tumor Ablation Needle Industry Chain
12.2 Tumor Ablation Needle Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Tumor Ablation Needle Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Tumor Ablation Needle Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Tumor Ablation Needle Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Tumor Ablation Needle Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Tumor Ablation Needle Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Tumor Ablation Needle Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Tumor Ablation Needle Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Tumor Ablation Needle Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Tumor Ablation Needle Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Tumor Ablation Needle Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Tumor Ablation Needle Sales by Region (2020-2025) & (K Units)
Table 8. Global Tumor Ablation Needle Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Tumor Ablation Needle Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Tumor Ablation Needle Sales Share by Manufacturers (2020-2025)
Table 12. Global Tumor Ablation Needle Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Tumor Ablation Needle Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Tumor Ablation Needle by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Ablation Needle as of 2024)
Table 16. Global Tumor Ablation Needle Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Tumor Ablation Needle Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Tumor Ablation Needle Manufacturing Base and Headquarters
Table 19. Global Tumor Ablation Needle Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Tumor Ablation Needle Sales by Type (2020-2025) & (K Units)
Table 23. Global Tumor Ablation Needle Sales by Type (2026-2031) & (K Units)
Table 24. Global Tumor Ablation Needle Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Tumor Ablation Needle Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Tumor Ablation Needle ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Tumor Ablation Needle Sales by Application (2020-2025) & (K Units)
Table 29. Global Tumor Ablation Needle Sales by Application (2026-2031) & (K Units)
Table 30. Tumor Ablation Needle High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Tumor Ablation Needle Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Tumor Ablation Needle Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Tumor Ablation Needle ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Tumor Ablation Needle Growth Accelerators and Market Barriers
Table 37. North America Tumor Ablation Needle Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Tumor Ablation Needle Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Tumor Ablation Needle Growth Accelerators and Market Barriers
Table 40. Europe Tumor Ablation Needle Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Tumor Ablation Needle Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Tumor Ablation Needle Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Tumor Ablation Needle Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Tumor Ablation Needle Growth Accelerators and Market Barriers
Table 45. Southeast Asia Tumor Ablation Needle Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Tumor Ablation Needle Investment Opportunities and Key Challenges
Table 47. Central and South America Tumor Ablation Needle Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Tumor Ablation Needle Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Tumor Ablation Needle Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Angiodynamics Corporation Information
Table 51. Angiodynamics Description and Major Businesses
Table 52. Angiodynamics Product Models, Descriptions and Specifications
Table 53. Angiodynamics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Angiodynamics Sales Value Proportion by Product in 2024
Table 55. Angiodynamics Sales Value Proportion by Application in 2024
Table 56. Angiodynamics Sales Value Proportion by Geographic Area in 2024
Table 57. Angiodynamics Tumor Ablation Needle SWOT Analysis
Table 58. Angiodynamics Recent Developments
Table 59. Boston Scientific Corporation Information
Table 60. Boston Scientific Description and Major Businesses
Table 61. Boston Scientific Product Models, Descriptions and Specifications
Table 62. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Boston Scientific Sales Value Proportion by Product in 2024
Table 64. Boston Scientific Sales Value Proportion by Application in 2024
Table 65. Boston Scientific Sales Value Proportion by Geographic Area in 2024
Table 66. Boston Scientific Tumor Ablation Needle SWOT Analysis
Table 67. Boston Scientific Recent Developments
Table 68. Medtronic Corporation Information
Table 69. Medtronic Description and Major Businesses
Table 70. Medtronic Product Models, Descriptions and Specifications
Table 71. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Medtronic Sales Value Proportion by Product in 2024
Table 73. Medtronic Sales Value Proportion by Application in 2024
Table 74. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 75. Medtronic Tumor Ablation Needle SWOT Analysis
Table 76. Medtronic Recent Developments
Table 77. Smith and Nephew Corporation Information
Table 78. Smith and Nephew Description and Major Businesses
Table 79. Smith and Nephew Product Models, Descriptions and Specifications
Table 80. Smith and Nephew Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Smith and Nephew Sales Value Proportion by Product in 2024
Table 82. Smith and Nephew Sales Value Proportion by Application in 2024
Table 83. Smith and Nephew Sales Value Proportion by Geographic Area in 2024
Table 84. Smith and Nephew Tumor Ablation Needle SWOT Analysis
Table 85. Smith and Nephew Recent Developments
Table 86. Starmed Corporation Information
Table 87. Starmed Description and Major Businesses
Table 88. Starmed Product Models, Descriptions and Specifications
Table 89. Starmed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Starmed Sales Value Proportion by Product in 2024
Table 91. Starmed Sales Value Proportion by Application in 2024
Table 92. Starmed Sales Value Proportion by Geographic Area in 2024
Table 93. Starmed Tumor Ablation Needle SWOT Analysis
Table 94. Starmed Recent Developments
Table 95. Siemens Corporation Information
Table 96. Siemens Description and Major Businesses
Table 97. Siemens Product Models, Descriptions and Specifications
Table 98. Siemens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Siemens Recent Developments
Table 100. PAJUNK Corporation Information
Table 101. PAJUNK Description and Major Businesses
Table 102. PAJUNK Product Models, Descriptions and Specifications
Table 103. PAJUNK Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. PAJUNK Recent Developments
Table 105. Johnson and Johnson Corporation Information
Table 106. Johnson and Johnson Description and Major Businesses
Table 107. Johnson and Johnson Product Models, Descriptions and Specifications
Table 108. Johnson and Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Johnson and Johnson Recent Developments
Table 110. Med-Italia Biomedica Corporation Information
Table 111. Med-Italia Biomedica Description and Major Businesses
Table 112. Med-Italia Biomedica Product Models, Descriptions and Specifications
Table 113. Med-Italia Biomedica Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Med-Italia Biomedica Recent Developments
Table 115. Thermedical Corporation Information
Table 116. Thermedical Description and Major Businesses
Table 117. Thermedical Product Models, Descriptions and Specifications
Table 118. Thermedical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Thermedical Recent Developments
Table 120. Erbe Elektromedizin GmbH Corporation Information
Table 121. Erbe Elektromedizin GmbH Description and Major Businesses
Table 122. Erbe Elektromedizin GmbH Product Models, Descriptions and Specifications
Table 123. Erbe Elektromedizin GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Erbe Elektromedizin GmbH Recent Developments
Table 125. Betters Medical Corporation Information
Table 126. Betters Medical Description and Major Businesses
Table 127. Betters Medical Product Models, Descriptions and Specifications
Table 128. Betters Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Betters Medical Recent Developments
Table 130. Nanjing ECO Microwave System Corporation Information
Table 131. Nanjing ECO Microwave System Description and Major Businesses
Table 132. Nanjing ECO Microwave System Product Models, Descriptions and Specifications
Table 133. Nanjing ECO Microwave System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Nanjing ECO Microwave System Recent Developments
Table 135. Nanjing MICRO-TECH Corporation Information
Table 136. Nanjing MICRO-TECH Description and Major Businesses
Table 137. Nanjing MICRO-TECH Product Models, Descriptions and Specifications
Table 138. Nanjing MICRO-TECH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Nanjing MICRO-TECH Recent Developments
Table 140. VISON Medical Corporation Information
Table 141. VISON Medical Description and Major Businesses
Table 142. VISON Medical Product Models, Descriptions and Specifications
Table 143. VISON Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. VISON Medical Recent Developments
Table 145. Nanjing Greatwall Wisemedical Tech Corporation Information
Table 146. Nanjing Greatwall Wisemedical Tech Description and Major Businesses
Table 147. Nanjing Greatwall Wisemedical Tech Product Models, Descriptions and Specifications
Table 148. Nanjing Greatwall Wisemedical Tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Nanjing Greatwall Wisemedical Tech Recent Developments
Table 150. Angel Medical Science and Technology Corporation Information
Table 151. Angel Medical Science and Technology Description and Major Businesses
Table 152. Angel Medical Science and Technology Product Models, Descriptions and Specifications
Table 153. Angel Medical Science and Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Angel Medical Science and Technology Recent Developments
Table 155. Leader Electronics Corporation Information
Table 156. Leader Electronics Description and Major Businesses
Table 157. Leader Electronics Product Models, Descriptions and Specifications
Table 158. Leader Electronics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Leader Electronics Recent Developments
Table 160. Zhuhai Hokai Medical Corporation Information
Table 161. Zhuhai Hokai Medical Description and Major Businesses
Table 162. Zhuhai Hokai Medical Product Models, Descriptions and Specifications
Table 163. Zhuhai Hokai Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Zhuhai Hokai Medical Recent Developments
Table 165. MedSphere International Corporation Information
Table 166. MedSphere International Description and Major Businesses
Table 167. MedSphere International Product Models, Descriptions and Specifications
Table 168. MedSphere International Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. MedSphere International Recent Developments
Table 170. Key Raw Materials Distribution
Table 171. Raw Materials Key Suppliers
Table 172. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 173. Milestones in Production Technology Evolution
Table 174. Distributors List
Table 175. Market Trends and Market Evolution
Table 176. Market Drivers and Opportunities
Table 177. Market Challenges, Risks, and Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Tumor Ablation Needle Product Picture
Figure 2. Global Tumor Ablation Needle Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Microwave Ablation Needle Product Picture
Figure 4. Radiofrequency Ablation Needle Product Picture
Figure 5. Cryoablation Needle Product Picture
Figure 6. Nanoknife Ablation Needle Product Picture
Figure 7. Global Tumor Ablation Needle Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Ambulatory Surgery Center
Figure 10. Other
Figure 11. Tumor Ablation Needle Report Years Considered
Figure 12. Global Tumor Ablation Needle Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 14. Global Tumor Ablation Needle Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Tumor Ablation Needle Revenue Market Share by Region (2020-2031)
Figure 16. Global Tumor Ablation Needle Sales (2020-2031) & (K Units)
Figure 17. Global Tumor Ablation Needle Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Tumor Ablation Needle Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Tumor Ablation Needle Sales Volume Market Share in 2024
Figure 20. Global Tumor Ablation Needle Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Microwave Ablation Needle Revenue Market Share by Manufacturer in 2024
Figure 23. Radiofrequency Ablation Needle Revenue Market Share by Manufacturer in 2024
Figure 24. Cryoablation Needle Revenue Market Share by Manufacturer in 2024
Figure 25. Nanoknife Ablation Needle Revenue Market Share by Manufacturer in 2024
Figure 26. Global Tumor Ablation Needle Sales Market Share by Type (2020-2031)
Figure 27. Global Tumor Ablation Needle Revenue Market Share by Type (2020-2031)
Figure 28. Global Tumor Ablation Needle Sales Market Share by Application (2020-2031)
Figure 29. Global Tumor Ablation Needle Revenue Market Share by Application (2020-2031)
Figure 30. North America Tumor Ablation Needle Sales YoY (2020-2031) & (K Units)
Figure 31. North America Tumor Ablation Needle Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Tumor Ablation Needle Sales Revenue (US$ Million) in 2024
Figure 33. North America Tumor Ablation Needle Sales Volume (K Units) by Type (2020- 2031)
Figure 34. North America Tumor Ablation Needle Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Tumor Ablation Needle Sales Volume (K Units) by Application (2020-2031)
Figure 36. North America Tumor Ablation Needle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Tumor Ablation Needle Sales YoY (2020-2031) & (K Units)
Figure 41. Europe Tumor Ablation Needle Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Tumor Ablation Needle Sales Revenue (US$ Million) in 2024
Figure 43. Europe Tumor Ablation Needle Sales Volume (K Units) by Type (2020-2031)
Figure 44. Europe Tumor Ablation Needle Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Tumor Ablation Needle Sales Volume (K Units) by Application (2020-2031)
Figure 46. Europe Tumor Ablation Needle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 48. France Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Tumor Ablation Needle Sales YoY (2020-2031) & (K Units)
Figure 53. Asia-Pacific Tumor Ablation Needle Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Tumor Ablation Needle Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Tumor Ablation Needle Sales Volume (K Units) by Type (2020- 2031)
Figure 56. Asia-Pacific Tumor Ablation Needle Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Tumor Ablation Needle Sales Volume (K Units) by Application (2020-2031)
Figure 58. Asia-Pacific Tumor Ablation Needle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 63. India Tumor Ablation Needle Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Tumor Ablation Needle Sales YoY (2020-2031) & (K Units)
Figure 65. Central and South America Tumor Ablation Needle Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Tumor Ablation Needle Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Tumor Ablation Needle Sales Volume (K Units) by Type (2021-2031)
Figure 68. Central and South America Tumor Ablation Needle Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Tumor Ablation Needle Sales Volume (K Units) by Application (2020-2031)
Figure 70. Central and South America Tumor Ablation Needle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Tumor Ablation Needle Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Tumor Ablation Needle Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Tumor Ablation Needle Sales YoY (2020-2031) & (K Units)
Figure 74. Middle East and Africa Tumor Ablation Needle Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Tumor Ablation Needle Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Tumor Ablation Needle Sales Volume (K Units) by Type (2021-2031)
Figure 77. South America Tumor Ablation Needle Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Tumor Ablation Needle Sales Volume (K Units) by Application (2020-2031)
Figure 79. Middle East and Africa Tumor Ablation Needle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Tumor Ablation Needle Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Tumor Ablation Needle Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Tumor Ablation Needle Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Tumor Ablation Needle Revenue (2020-2025) & (US$ Million)
Figure 84. Tumor Ablation Needle Industry Chain Mapping
Figure 85. Regional Tumor Ablation Needle Manufacturing Base Distribution (%)
Figure 86. Global Tumor Ablation Needle Production Market Share by Region (2020-2031)
Figure 87. Tumor Ablation Needle Production Process
Figure 88. Regional Tumor Ablation Needle Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Tumor Ablation Needle in 2025?
The global market size of Tumor Ablation Needle in 2025 was 1299 Million USD.
What was the global market size of Tumor Ablation Needle in 2031?
What is the annual compound growth rate of the global Tumor Ablation Needle market size from 2025 to 2031?
Which companies rank high in the global Tumor Ablation Needle market?
Which region is expected to have the highest market share?
Related Reports
Tumor Ablation Needle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tumor Ablation Needle was estimated to be worth US$ 1299 million in 2025 and is projected to reach US$ 2282 million, growing at a CAGR of 8.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 154
USD 3950.00
(Single User License)
Global Tumor Ablation Needle Market Research Report 2026
The global Tumor Ablation Needle market was valued at US$ 1299 million in 2025 and is anticipated to reach US$ 2282 million by 2032, at a CAGR of 8.5% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 137
USD 2900.00
(Single User License)
Global Tumor Ablation Needle Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tumor Ablation Needle market size was US$ 1207 million in 2024 and is forecast to a readjusted size of US$ 2119 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 106
USD 4250.00
(Single User License)
Global Tumor Ablation Needle Market Research Report 2025
The global market for Tumor Ablation Needle was valued at US$ 1207 million in the year 2024 and is projected to reach a revised size of US$ 2119 million by 2031, growing at a CAGR of 8.5% during the forecast period.
Published Date: 2025-01-16
Pages: 107
USD 2900.00
(Single User License)
Tumor Ablation Needle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tumor Ablation Needle was estimated to be worth US$ 1207 million in 2024 and is forecast to a readjusted size of US$ 2119 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 150
USD 3950.00
(Single User License)
Global Tumor Ablation Needle Market Insights, Forecast to 2030
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
Published Date: 2024-04-12
Pages: 128
USD 4900.00
(Single User License)
Global Tumor Ablation Needle Market Research Report 2024
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
Published Date: 2024-01-17
Pages: 113
USD 2900.00
(Single User License)
Tumor Ablation Needle - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
Published Date: 2024-01-10
Pages: 174
USD 3950.00
(Single User License)
Tumor Ablation Needle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tumor Ablation Needle was estimated to be worth US$ 1299 million in 2025 and is projected to reach US$ 2282 million, growing at a CAGR of 8.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 154
USD 3950.00 (Single User License)Global Tumor Ablation Needle Market Research Report 2026
The global Tumor Ablation Needle market was valued at US$ 1299 million in 2025 and is anticipated to reach US$ 2282 million by 2032, at a CAGR of 8.5% from 2026 to 2032.
Published: 2026-04-17
Pages: 137
USD 2900.00 (Single User License)Global Tumor Ablation Needle Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tumor Ablation Needle market size was US$ 1207 million in 2024 and is forecast to a readjusted size of US$ 2119 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 106
USD 4250.00 (Single User License)Global Tumor Ablation Needle Market Research Report 2025
The global market for Tumor Ablation Needle was valued at US$ 1207 million in the year 2024 and is projected to reach a revised size of US$ 2119 million by 2031, growing at a CAGR of 8.5% during the forecast period.
Published: 2025-01-16
Pages: 107
USD 2900.00 (Single User License)Tumor Ablation Needle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tumor Ablation Needle was estimated to be worth US$ 1207 million in 2024 and is forecast to a readjusted size of US$ 2119 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 150
USD 3950.00 (Single User License)Global Tumor Ablation Needle Market Insights, Forecast to 2030
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
Published: 2024-04-12
Pages: 128
USD 4900.00 (Single User License)Global Tumor Ablation Needle Market Research Report 2024
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
Published: 2024-01-17
Pages: 113
USD 2900.00 (Single User License)Tumor Ablation Needle - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
Published: 2024-01-10
Pages: 174
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now